Literature DB >> 9109853

Plasma leptin concentrations and energy expenditure in heart failure patients.

M J Toth1, S S Gottlieb, M L Fisher, A S Ryan, B J Nicklas, E T Poehlman.   

Abstract

Leptin, the protein encoded by the obese gene, is a newly described hormone implicated in the regulation of energy balance. To examine the possible role of leptin in the energy dysregulation that frequently accompanies chronic heart failure, we examined plasma leptin concentrations and energy expenditure in 18 heart failure patients (aged 71 +/- 6 years) and 46 healthy elderly controls (66 +/- 6 years). Plasma leptin concentrations were measured by radioimmunoassay, daily energy expenditure by doubly labeled water, and body composition by dual-energy x-ray absorptiometry. Fat mass was lower (P < .01) in heart failure patients compared with healthy controls, whereas fat-free mass did not differ between groups. Plasma leptin concentrations were not different between heart failure patients and healthy controls (5.1 +/- 4.2 v 6.8 +/- 4.4 pg/mL) and remained similar after statistical control for fat mass (6.0 +/- 3.1 v 7.1 +/- 3.2 pg/mL). Plasma leptin was related to fat mass in heart failure patients (r = .92, P < .01) and healthy controls (r = .69, P < .01). Free-living daily and physical-activity energy expenditures were lower (P < .01) in heart failure patients compared with healthy controls. Plasma leptin concentrations were related to both daily (r = .67, P < .01) and resting (r = .67, P < .01) energy expenditure in heart failure patients, but not in healthy controls (r = .09 and r = .33, respectively). In conclusion, we found an association between plasma leptin concentrations and energy expenditure in heart failure patients, but not in healthy controls. Thus, leptin may participate in the regulation of energy expenditure and body energy stores in heart failure patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109853     DOI: 10.1016/s0026-0495(97)90065-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Role of NF-κB and p38 MAPK activation in mediating angiotensin II and endothelin-1-induced stimulation in leptin production and cardiomyocyte hypertrophy.

Authors:  Venkatesh Rajapurohitam; Ana Kilic; Sabzali Javadov; Morris Karmazyn
Journal:  Mol Cell Biochem       Date:  2012-04-20       Impact factor: 3.396

2.  Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.

Authors:  D Kovacić; M Marinsek; L Gobec; M Lainscak; M Podbregar
Journal:  Clin Res Cardiol       Date:  2007-08-17       Impact factor: 5.460

3.  Leptin, leptin gene and leptin receptor gene polymorphism in heart failure with preserved ejection fraction.

Authors:  Tarek A Abd El-Aziz; Randa H Mohamed; Rasha H Mohamed; Heba F Pasha
Journal:  Heart Vessels       Date:  2011-05-17       Impact factor: 2.037

4.  Obesity, Inflammation and Acute Myocardial Infarction - Expression of leptin, IL-6 and high sensitivity-CRP in Chennai based population.

Authors:  Karthick Rajendran; Nalini Devarajan; Manohar Ganesan; Malathi Ragunathan
Journal:  Thromb J       Date:  2012-08-14

5.  Leptin in anorexia and cachexia syndrome.

Authors:  Diana R Engineer; Jose M Garcia
Journal:  Int J Pept       Date:  2012-02-08

6.  The obesity-related peptide leptin sensitizes cardiac mitochondria to calcium-induced permeability transition pore opening and apoptosis.

Authors:  Eduardo Martinez-Abundis; Venkatesh Rajapurohitam; James V Haist; Xiaohong T Gan; Morris Karmazyn
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.